1	Cortivazol	Cortivazol	_	_	_	_	_	_	_
2	mediated	mediate	_	_	_	_	_	_	_
3	induction	induction	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	messenger	messenger	_	_	_	_	_	_	_
8	ribonucleic	ribonucleic	_	_	_	_	_	_	_
9	acid	acid	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	wild-type	wild-type	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	dexamethasone-resistant	dexamethasone-resistant	_	_	_	_	_	_	_
14	human	human	_	_	_	_	_	_	_
15	leukemic	leukemic	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	CEM	CEM	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Cortivazol	Cortivazol	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	phenylpyrazolo	phenylpyrazolo	_	_	_	_	_	_	_
5	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	high	high	_	_	_	_	_	_	_
8	potency	potency	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	unusual	unusual	_	_	_	_	_	_	_
11	structure	structure	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	both	both	_	_	_	_	_	_	_
3	wild-type	wild-type	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	highly	highly	_	_	_	_	_	_	_
6	dexamethasone(dex)-resistant	dexamethasone(dex)-resistant	_	_	_	_	_	_	_
7	clones	clone	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	leukemic	leukemic	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	line	line	_	_	_	_	_	_	_
14	CEM	CEM	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	exposure	exposure	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	cortivazol	cortivazol	_	_	_	_	_	_	_
19	leads	lead	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	death	death	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	has	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	recently	recently	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	wild-type	wild-type	_	_	_	_	_	_	_
9	CEM	CEM	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	but	but	_	_	_	_	_	_	_
12	not	not	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	dex-resistant	dex-resistant	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
18	receptor(GR)-defective	receptor(gr)-defective	_	_	_	_	_	_	_
19	clone	clone	_	_	_	_	_	_	_
20	ICR-27	icr-27	_	_	_	_	_	_	_
21	TK-3	tk-3	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	dex	dex	_	_	_	_	_	_	_
24	induces	induce	_	_	_	_	_	_	_
25	GR	GR	_	_	_	_	_	_	_
26	mRNA	mRNA	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	test	test	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	hypothesis	hypothesis	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	cortivazol	cortivazol	_	_	_	_	_	_	_
7	acts	act	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	dex-resistant	dex-resistant	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	making	make	_	_	_	_	_	_	_
13	use	use	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	residual	residual	_	_	_	_	_	_	_
17	GR	gr	_	_	_	_	_	_	_
18	found	find	_	_	_	_	_	_	_
19	there	there	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	wild-type	wild-type	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	dex-resistant	dex-resistant	_	_	_	_	_	_	_
24	clones	clone	_	_	_	_	_	_	_
25	were	be	_	_	_	_	_	_	_
26	treated	treat	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	various	various	_	_	_	_	_	_	_
29	concentrations	concentration	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	cortivazol	cortivazol	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	induction	induction	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	GR	GR	_	_	_	_	_	_	_
36	mRNA	mRNA	_	_	_	_	_	_	_
37	was	be	_	_	_	_	_	_	_
38	studied	study	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Cortivazol	Cortivazol	_	_	_	_	_	_	_
2	significantly	significantly	_	_	_	_	_	_	_
3	induced	induce	_	_	_	_	_	_	_
4	GR	GR	_	_	_	_	_	_	_
5	mRNA	mRNA	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	normal	normal	_	_	_	_	_	_	_
9	CEM-C7	cem-c7	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	well	well	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	two	two	_	_	_	_	_	_	_
15	classes	class	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	dex-resistant	dex-resistant	_	_	_	_	_	_	_
18	clones	clone	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	although	although	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	dex-resistant	dex-resistant	_	_	_	_	_	_	_
23	clones	clone	_	_	_	_	_	_	_
24	needed	need	_	_	_	_	_	_	_
25	at	at	_	_	_	_	_	_	_
26	least	least	_	_	_	_	_	_	_
27	10	10	_	_	_	_	_	_	_
28	times	time	_	_	_	_	_	_	_
29	more	more	_	_	_	_	_	_	_
30	cortivazol	cortivazol	_	_	_	_	_	_	_
31	than	than	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	normal	normal	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	for	for	_	_	_	_	_	_	_
36	significant	significant	_	_	_	_	_	_	_
37	GR	GR	_	_	_	_	_	_	_
38	mRNA	mrna	_	_	_	_	_	_	_
39	induction	induction	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Increased	increase	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	GR	GR	_	_	_	_	_	_	_
5	mRNA	mRNA	_	_	_	_	_	_	_
6	were	be	_	_	_	_	_	_	_
7	noticed	notice	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	early	early	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	3	3	_	_	_	_	_	_	_
12	h	h	_	_	_	_	_	_	_
13	after	after	_	_	_	_	_	_	_
14	treatment	treatment	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	general	general	_	_	_	_	_	_	_
3	correlation	correlation	_	_	_	_	_	_	_
4	between	between	_	_	_	_	_	_	_
5	induction	induction	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	GR	GR	_	_	_	_	_	_	_
8	mRNA	mRNA	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	lysis	lysis	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	normal	normal	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	dex-resistant	dex-resistant	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	found	find	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Positive	positive	_	_	_	_	_	_	_
2	induction	induction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	GR	GR	_	_	_	_	_	_	_
5	mRNA	mRNA	_	_	_	_	_	_	_
6	might	might	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	one	one	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	earliest	early	_	_	_	_	_	_	_
12	crucial	crucial	_	_	_	_	_	_	_
13	steps	step	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	lysis	lysis	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	normal	normal	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	dex-resistant	dex-resistant	_	_	_	_	_	_	_
21	CEM	CEM	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	or	or	_	_	_	_	_	_	_
25	might	might	_	_	_	_	_	_	_
26	serve	serve	_	_	_	_	_	_	_
27	as	as	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	marker	marker	_	_	_	_	_	_	_
30	for	for	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	process	process	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	lysis	lysis	_	_	_	_	_	_	_
5	pathway	pathway	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	dex-resistant	dex-resistant	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	defective	defective	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	dex-resistant	dex-resistant	_	_	_	_	_	_	_
15	clones	clone	_	_	_	_	_	_	_
16	needed	need	_	_	_	_	_	_	_
17	significantly	significantly	_	_	_	_	_	_	_
18	more	more	_	_	_	_	_	_	_
19	cortivazol	cortivazol	_	_	_	_	_	_	_
20	than	than	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	normal	normal	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	for	for	_	_	_	_	_	_	_
25	lysis	lysis	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

